1. Signaling Pathways
  2. NF-κB
  3. NF-κB

NF-κB (核因子κB)

Nuclear factor-κB; Nuclear factor-kappaB

NF-κB(活化 B 细胞的核因子 κ 轻链增强子)是一种控制 DNA 转录的蛋白质复合物。NF-κB 存在于几乎所有动物细胞类型中,并参与细胞对压力、细胞因子、自由基、紫外线照射、氧化 LDL 以及细菌或病毒抗原等刺激的反应。NF-κB 在调节对感染的免疫反应中起着关键作用。NF-κB 的错误调节与癌症、炎症和自身免疫性疾病、感染性休克、病毒感染和免疫发育不当有关。NF-κB 还与突触可塑性和记忆过程有关。哺乳动物 NF-κB 家族中有五种蛋白质:NF-κB1、NF-κB2、RelA、RelB、c-Rel。

NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein complex that controls transcription of DNA. NF-κB is found in almost all animal cell types and is involved in cellular responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens. NF-κB plays a key role in regulating the immune response to infection. Incorrect regulation of NF-κB has been linked to cancer, inflammatory, and autoimmune diseases, septic shock, viral infection, and improper immune development. NF-κB has also been implicated in processes of synaptic plasticity and memory. There are five proteins in the mammalian NF-κB family: NF-κB1, NF-κB2, RelA, RelB, c-Rel.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-N0427
    Phellodendrine

    黄柏碱

    Inhibitor 99.60%
    Phellodendrine 是一种异喹啉生物碱,是黄柏皮层中的重要特征成分之一。Phellodendrine 通过调节 AKT/NF-κB 途径抵抗 AAPH 诱导的氧化应激。Phellodendrine 具有良好的抗氧化,抗炎作用。
    Phellodendrine
  • HY-N7980
    Rubipodanone A Activator 99.40%
    Rubipodanone A 是一种萘氢醌二聚体,对 A549、BEL-7402、HeLa、HepG2、SGC-7901 和 U251 细胞具有细胞毒性。Rubipodanone A 在 20 μM 和 40 μM 对 NF-κB 也显示出明显的激活作用。
    Rubipodanone A
  • HY-107566
    Conessine Inhibitor 99.87%
    Conessine 是一种口服有效且能透过血脑屏障的选择性组胺 H3 受体拮抗剂。Conessine 对大鼠和人 H3 受体的 pKi 为 7.61 和 8.27。Conessine 是 Pseudomonas aeruginosa 中多药物外排泵系统的抑制剂,可增强抗生素的活性。Conessine 具有抗疟疾活性。Conessine 也可用于肌肉萎缩的研究。
    Conessine
  • HY-N2590
    Lupenone 99.74%
    Lupenone 是一种具有口服活性的可从 Musa basjoo 中分离出的 lupine 型三萜类化合物。Lupenone Lupenone 可通过 PI3K/Akt/mTORNF-κB 信号通路发挥作用。Lupenone 具有抗炎、抗病毒、抗糖尿病和抗癌活性。
    Lupenone
  • HY-W001925
    7-Methoxy-1-tetralone Inhibitor 99.93%
    7-Methoxy-1-tetralone 是一种强效的抗肿瘤试剂。7-Methoxy-1-tetralone 抑制癌细胞增殖和迁徙,并诱导肝细胞癌细胞 (HCC) 凋亡 (apoptosis)。7-Methoxy-1-tetralone 能够降低 NF-κB、基质金属肽酶 2 (MMP2)/MMP9 和 p-AKT 的蛋白水平。7-Methoxy-1-tetralone 在裸鼠体内具有抗肿瘤活性,对体重和肝脾脏器指数没有影响。
    7-Methoxy-1-tetralone
  • HY-164102
    TNF-α-IN-18 Inhibitor 98.94%
    TNF-α-IN-18 (Compound 61) 是 TNF-α 的抑制剂 (IC50 为 1.8 μM),通过阻断 NF-kB 从细胞质迁移到细胞核来抑制 TNF 信号通路。TNF-α-IN-18 对小鼠成纤维细胞 LM 表现出轻微的细胞毒性,CC50 >50 μM。TNF-α-IN-18 可改善小鼠模型中 TNF 或 Lipopolysaccharide (HY-D1056) 诱发的脓毒症。TNF-α-IN-18 可保护小鼠免受类风湿性关节炎。
    TNF-α-IN-18
  • HY-106449
    Recoflavone Inhibitor ≥98.0%
    Recoflavone (DA-6034 (free acid)) 是一种黄酮类化合物 Eupatilin (HY-N0783) 的合成衍生物,具有口服活性。Recoflavone 可抑制 NF-κB 通路。Recoflavone 也可诱导上皮细胞内钙离子浓度升高。Recoflavone 具有抗炎、抗肿瘤、胃黏膜、肠粘膜保护和促进眼表、唾液腺分泌等活性。Recoflavone 可用于干眼症、胃损伤和肠损伤等疾病的研究。
    Recoflavone
  • HY-12383
    Pelubiprofen Inhibitor 99.27%
    Pelubiprofen 是一种具有口服活性的抗炎剂,可抑制 COX 酶活性 (对 COX-1COX-2IC50 为 10.66 和 2.88 μM)。Pelubiprofen 具有抗炎和镇痛作用。
    Pelubiprofen
  • HY-N1380R
    Guaiacol (Standard)

    愈创木酚 (标准品);

    Inhibitor
    Guaiacol (Standard) 是 Guaiacol 的分析标准品。本产品用于研究及分析应用。Guaiacol 是一种酚类化合物,抑制 LPS 刺激的 COX-2 表达和 NF-κB 激活。具有抗炎活性。
    Guaiacol (Standard)
  • HY-P1860A
    TNF-α (31-45), human TFA Activator
    TNF-α (31-45), human TFA 是一种有效的 NF-kB 通路激活剂,也是一种促炎细胞因子,可诱导坏死或凋亡。TNF α 通过 TNFR2 刺激 NF-κB 通路,促进癌症生长、侵袭和转移。
    TNF-α (31-45), human TFA
  • HY-168328
    FKK6 Inhibitor 99.14%
    FKK6 是孕烷 X 受体 (PXR) 的选择性激动剂,EC50 为 1.2 µM。FKK6 与血浆蛋白具有良好的亲和性,并且在人类微粒体中具有良好的代谢特性。FKK6 抑制 PXR 相关的 NF-κB 信号通路,抑制炎症因子的表达,并在小鼠模型中对 DSS (HY-116282) 诱发的结肠炎表现出抗炎活性。
    FKK6
  • HY-111954
    (+)-Erinacin A 99.97%
    (+)-Erinacin A (Erinacine A) 是一种可从猴头菌中分离出的氰烷二萜,具有抗癌,抗炎和神经保护活性。(+)-Erinacin A 能够通过激活了外源性和内源性凋亡 (apoptosis) 途径引发癌细胞死亡。(+)-Erinacin A 也能抑制 NO 合成酶 (iNOS) 的表达和硝基酪氨酸的产生来发挥炎症和神经保护作用,从而减少缺血性脑损伤。
    (+)-Erinacin A
  • HY-N3796
    Echinulin Activator 98.63%
    Echinulin (Echinuline) 是一种带有三苯甲基化吲哚部分的环状二肽。 Echinulin 有助于激活 T 细胞亚群,从而导致 NF-κB 活化。Echinulin 通过 NF-κB 途径发挥其免疫作用。Echinulin 具有作为免疫抑制剂的潜力。
    Echinulin
  • HY-121955
    FW1256 Inhibitor
    FW1256 是一种苯基类似物,也是一种缓释硫化氢 (H2S) 供体。FW1256 抑制 NF-κB 活性,并可诱导细胞凋亡 (apoptosis),具有有效的抗炎作用,并可用于癌症和心血管疾病的研究。
    FW1256
  • HY-N2106
    Dehydroevodiamine

    去氢吴茱萸碱

    99.93%
    Dehydroevodiamine 是从吴茱萸 Evodiae Fructus 中分离出的喹唑啉生物碱,对豚鼠心室肌细胞具有抗心律失常作用。Dehydroevodiamine 抑制 LPS 诱导的小鼠巨噬细胞中 iNOSCOX-2PGE2NF-κB 的表达。
    Dehydroevodiamine
  • HY-N10303
    Withangulatin A Inhibitor 99.76%
    Withangulatin A 是 COX-2 的抑制剂。Withangulatin A 可抑制 MAPKNF-κBAkt/mTOR/p70S6K 通路,具有抗肿瘤、抗炎和杀锥虫活性。
    Withangulatin A
  • HY-N0708R
    Vanillic acid (Standard)

    香草酸 (Standard)

    Inhibitor
    Vanillic acid (Standard) 是 Vanillic acid 的分析标准品。本产品用于研究及分析应用。Vanillic acid 是一种在食用植物和水果中发现的调味剂,在当归根部也可以发现。Vanillic acid 抑制 NF-κB 活化。具有抗炎,抗菌等活性。
    Vanillic acid (Standard)
  • HY-10227R
    Bortezomib (Standard)

    硼替佐米(Standard)

    Inhibitor
    Bortezomib (Standard)是 Bortezomib 的分析标准品。本产品用于研究及分析应用。Bortezomib (PS-341) 是一种可逆性和选择性的蛋白酶体 (proteasome) 抑制剂,通过靶向苏氨酸残基有效抑制 20S 蛋白酶体 (Ki=0.6 nM)。Bortezomib 破坏细胞周期、诱导细胞凋亡以及抑制核因子 NF-κB。Bortezomib 是第一种蛋白酶体抑制剂,具有抗癌活性。
    Bortezomib (Standard)
  • HY-B1449R
    Uridine (Standard)

    尿苷 (Standard)

    Inhibitor
    Uridine (Standard) 是 Uridine 的分析标准品。本产品用于研究及分析应用。Uridine (β-Uridine) 是一种核苷化合物,由尿嘧啶与核糖环组成,两者由β-N1-配糖键相连。
    Uridine (Standard)
  • HY-13010S
    Laquinimod-d5 Inhibitor 98.25%
    Laquinimod-d5 (ABR-215062-d5) 是 Laquinimod 氚代物。Laquinimod (ABR-215062) 是一种可口服的羧酰胺衍生物,是一种有效的免疫调节剂,可防止中枢神经系统的神经变性和炎症。Laquinimod 减少星形胶质细胞 NF-κB 的活化以防止铜酮 (Cuprizone) 诱导的脱髓鞘。Laquinimod 具有用于多发性硬化症 (MS;RRMS 或 CPMS) 的复发缓解 (RR) 和慢性进行性 (CP) 形式以及神经退行性疾病研究的潜力。
    Laquinimod-d<sub>5</sub>
目录号 产品名 / 同用名 应用 反应物种

NF-κB transcription factors are critical regulators of immunity, stress responses, apoptosis and differentiation. In mammals, there are five members of the transcription factor NF-κB family: RELA (p65), RELB and c-REL, and the precursor proteins NF-κB1 (p105) and NF-κB2 (p100), which are processed into p50 and p52, respectively. NF-κB transcription factors bind as dimers to κB sites in promoters and enhancers of a variety of genes and induce or repress transcription. NF-κB activation occurs via two major signaling pathways: the canonical and the non-canonical NF-κB signaling pathways[1]

 

The canonical NF-κB pathway is triggered by signals from a large variety of immune receptors, such as TNFR, TLR, and IL-1R, which activate TAK1. TAK1 then activates IκB kinase (IKK) complex, composed of catalytic (IKKα and IKKβ) and regulatory (NEMO) subunits, via phosphorylation of IKKβ. Upon stimulation, the IKK complex, largely through IKKβ, phosphorylates members of the inhibitor of κB (IκB) family, such as IκBα and the IκB-like molecule p105, which sequester NF-κB members in the cytoplasm. IκBα associates with dimers of p50 and members of the REL family (RELA or c-REL), whereas p105 associates with p50 or REL (RELA or c-REL). Upon phosphorylation by IKK, IκBα and p105 are degradated in the proteasome, resulting in the nuclear translocation of canonical NF-κB family members, which bind to specific DNA elements, in the form of various dimeric complexes, including RELA-p50, c-REL-p50, and p50-p50. Atypical, IKK-independent pathways of NF-κB induction also provide mechanisms to integrate parallel signaling pathways to increase NF-κB activity, such as hypoxia, UV and genotoxic stress.

 

The non-canonical NF-κB pathway is induced by certain TNF superfamily members, such as CD40L, BAFF and lymphotoxin-β (LT-β), which stimulates the recruitment of TRAF2, TRAF3, cIAP1/2 to the receptor complex. Activated cIAP mediates K48 ubiquitylation and proteasomal degradation of TRAF3, resulting in stabilization and accumulation of the NFκB-inducing kinase (NIK). NIK phosphorylates and activates IKKα, which in turn phosphorylates p100, triggering p100 processing, and leading to the generation of p52 and the nuclear translocation of p52 and RELB[2][3].

 

Reference:

[1]. Oeckinghaus A, et al. The NF-kappaB family of transcription factors and its regulation.Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034. 
[2]. Taniguchi K, et al. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018 May;18(5):309-324.
[3]. Perkins ND,et al. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.